2017
DOI: 10.1016/j.gastrohep.2016.05.005
|View full text |Cite
|
Sign up to set email alerts
|

Mastocytic enterocolitis: Increase of mast cells in the gastrointestinal tract of patients with chronic diarrhea

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 10 publications
0
1
0
Order By: Relevance
“…Initial treatment consists of histamine H1 and H2 receptor blockers, such as cetirizine and famotidine respectively, that inhibit mast cell release and function. Alternatively, cromolyn sodium can be used to prevent mediator release from mast cells [ 17 ]. In patients with refractory symptoms despite the initial treatment, steroids such as oral budesonide and beclomethasone dipropionate have been shown to be beneficial by addressing mucosal inflammation [ 18 ].…”
Section: Discussionmentioning
confidence: 99%
“…Initial treatment consists of histamine H1 and H2 receptor blockers, such as cetirizine and famotidine respectively, that inhibit mast cell release and function. Alternatively, cromolyn sodium can be used to prevent mediator release from mast cells [ 17 ]. In patients with refractory symptoms despite the initial treatment, steroids such as oral budesonide and beclomethasone dipropionate have been shown to be beneficial by addressing mucosal inflammation [ 18 ].…”
Section: Discussionmentioning
confidence: 99%